Madrid, Spain

Cecilia Guzman

This inventor holds 1 USPTO granted patent. Top assignee: Pharma Mar, S.a.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cecilia Guzman. Retrieved from https://idiyas.com/inventor/cecilia-guzman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cecilia Guzman: Innovator in Cancer Treatment

Introduction

Cecilia Guzman is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of medicine, particularly in cancer treatment. Her innovative work has led to the development of a unique medicament that holds promise for patients battling cancer.

Latest Patents

Cecilia holds a patent for "Compositions and uses of ET743 for treating cancer." This patent focuses on the use of ET743 in the preparation of a medicament aimed at treating the human body for cancer. Her groundbreaking research in this area has the potential to improve treatment outcomes for many patients.

Career Highlights

Cecilia is associated with Pharma Mar, S.A., a company known for its commitment to developing innovative therapies for cancer treatment. Her work at Pharma Mar has been instrumental in advancing the understanding and application of ET743 in clinical settings.

Collaborations

Cecilia has collaborated with esteemed colleagues such as Esteban Cvitkovich and Luis Lopez Lazaro. These partnerships have enriched her research and contributed to the successful development of her patented treatments.

Conclusion

Cecilia Guzman's contributions to cancer treatment through her innovative patent demonstrate her dedication to improving patient care. Her work continues to inspire advancements in medical research and therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…